GK and monthly revision

Avience Biomedicals shares may make a strong debut as GMP signals 62% premium ahead of listing

Avience Biomedicals has launched an IPO worth Rs 30.24 crore, consisting of 14.54 lakh fresh shares. The IPO was met with exceptional investor interest, achieving a subscription rate of 385.32 times during the three-day bidding period. This overwhelming response highlights the growing confidence in the biotech sector and may indicate a trend towards increased investments in similar IPOs. Such developments are crucial for understanding market dynamics and investor behavior in the economy.